Roland Turck, MD
Executive in Residence
Dr. Roland Turck is an international Biotech-Pharma Executive and Medical Doctor experienced in both Big Pharma and Biotech. He has founded the consulting firm TurckBio that supports executive teams, boards, and investors of biotech companies. TurckBio provides advice on strategy, clinical development, and commercialization in the specialty medicine field. Roland has a proven P&L track record and the ability to translate science into commercial success, he has built businesses, expanded franchises, launched brands, and has driven commercial performance at the global, regional, and country-level in both mature and emerging market. He has driven profitable growth of portfolios ranging from 20 MM US$ to 4,000 MM US$. Roland is considered an expert in Specialty Medicine and has extensive first-hand experience and a deep understanding of clinical development, strategy, and commercialization in Oncology, Neurology, Orphan Drugs, Radiopharmaceuticals, Diagnostic and Molecular Imaging. Prior to TurckBio, Roland co-founded an Immuno-oncology company (recently sold). In his corporate career, Roland was President of Bayer’s Global Specialty Medicine business, where he increased portfolio value by 40%. He orchestrated the launch of major brands such as Xofigo, Eylea, and Stivarga, transformed Oncology into a rapidly growing sustainable franchise, unlocking the value of the underperforming Diagnostic Imaging business, entered Ophthalmology, and turned the Hemophilia business around. In his prior operational role as Region Head for Latin America, he successfully led the integration of Bayer and Schering, achieved faster than market growth while driving profitability, and expanded portfolio through deals. Roland is a strategic mind firmly grounded in reality owing to his extensive operative experience. He gained hands-on experience in various country organizations, he gained strategic experience as a member of the Bayer Pharma Global Executive Committee and in his other senior executive roles. Throughout his career, Roland has led organizations through various challenges such as acquisitions, integration, rapid growth periods, scaling-up, restructuring, turnaround, downsizing, and these experiences have made him very versatile. Roland is truly a global player who understands both mature and emerging markets. He experienced the value of diversity working and living on all continents.